Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-12-04
1992-08-25
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142285, 5142332, 514255, 514293, A61K 3138, A61K 3141
Patent
active
051419327
ABSTRACT:
The invention discloses certain 5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines useful as PAF receptor antagonists and for treating tumors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method of using such compositions for inhibiting PAF-mediated bronchoconstriction and extravasation, for controlling hyperreactive airways, for protecting against endotoxin-induced hypotension and death and for treating tumors.
REFERENCES:
patent: 4100165 (1978-07-01), Houlihan
patent: 4101553 (1981-07-01), Houlihan
patent: 4279912 (1981-07-01), Ages et al.
Cheon Seung H.
Houlihan William J.
Borovian Joseph J.
Honor Robert S.
Richter Johann
Sandoz Pharmaceuticals Corp.
Sharkin Gerald D.
LandOfFree
5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno py does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno py, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-Aryl-substituted-2,3-dihydro-imidazo(1,2-a)furo- and thieno py will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385125